SCARA5 and cancer: To estimate DNA hypermethylation in our cancer context, we first studied whether treatment with the demethylating agent 5’-azacitidine (5-Aza) increased the expression of SCARA5 and/or AOX1. Supplementary Fig. 9A, B shows significantly increased levels of SCARA5 (in 7/10 cell lines) and AOX1 (in 4/10 cell lines) upon treatment with 5-Aza.